Human mammaglobin

Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer

G. - W. Lee, Kim, J. - Y., Koh, E. - H., Kang, D., Choi, D. S., Maeng, K. - Y., and Lee, J. - S., Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer, vol. 11, pp. 4034-4042, 2012.

Different treatment outcomes and prognoses in patients with breast cancer can be observed with similar clinical predictors; this is because the biology of breast cancer is complex and heterogenous, involving multiple unknown contributing factors. We looked for plasma human mammaglobin (hMAM) mRNA by RT-PCR in 82 Korean patients with breast cancer to determine if there is an association between the presence of plasma hMAM mRNA in these patients and known prognostic factors.

Subscribe to Human mammaglobin